Taurolidine
- Generic Name
- Taurolidine
- Drug Type
- Small Molecule
- Chemical Formula
- C7H16N4O4S2
- CAS Number
- 19388-87-5
- Unique Ingredient Identifier
- 8OBZ1M4V3V
Overview
Taurolidine has been investigated for the prevention of Central Venous Catheter, Home Parenteral Nutrition, and Catheter-Related Infections.
Background
Taurolidine has been investigated for the prevention of Central Venous Catheter, Home Parenteral Nutrition, and Catheter-Related Infections.
Indication
Not Available
Associated Conditions
- Infection
- Soft Tissues Infections
- Tissue Adhesions
- Perioperative infection
Clinical Trials
FDA Approved Products
DEFENCATH
Manufacturer:CorMedix Inc.
Route:INTRALUMINAL
Strength:40.5 mg in 3 mL
Approved: 2023/12/21
NDC:72990-103
DEFENCATH
Manufacturer:CorMedix Inc.
Route:INTRALUMINAL
Strength:67.5 mg in 5 mL
Approved: 2023/12/21
NDC:72990-105
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath